BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 11566041)

  • 21. Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
    Milas L
    Am J Clin Oncol; 2003 Aug; 26(4):S66-9. PubMed ID: 12902859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of endogenous prostaglandins and cyclooxygenase isozymes in healing of indomethacin-induced small intestinal lesions in rats.
    Hatazawa R; Ohno R; Tanigami M; Tanaka A; Takeuchi K
    J Pharmacol Exp Ther; 2006 Aug; 318(2):691-9. PubMed ID: 16699067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclooxygenase 2: from inflammation to carcinogenesis.
    Ristimäki A
    Novartis Found Symp; 2004; 256():215-21; discussion 221-6, 259-69. PubMed ID: 15027493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase-2 inhibitors in lung cancer.
    Ramalingam S; Belani CP
    Clin Lung Cancer; 2004 Jan; 5(4):245-53. PubMed ID: 14967078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. COX-1 and COX-2 inhibitors.
    Hawkey CJ
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):801-20. PubMed ID: 11566042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
    Koki AT; Khan NK; Woerner BM; Seibert K; Harmon JL; Dannenberg AJ; Soslow RA; Masferrer JL
    Prostaglandins Leukot Essent Fatty Acids; 2002 Jan; 66(1):13-8. PubMed ID: 12051953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclooxygenase-2 inhibitors: promise or peril?
    Mengle-Gaw LJ; Schwartz BD
    Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcriptional regulation of cyclo-oxygenase expression: three pillars of control.
    Ramsay RG; Ciznadija D; Vanevski M; Mantamadiotis T
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):59-67. PubMed ID: 14552705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Coxibs: highly selective cyclooxygenase-2 inhibitors. Part I. Clinical efficacy].
    Burdan F; Korobowicz A
    Pol Merkur Lekarski; 2003 Apr; 14(82):348-51. PubMed ID: 12868200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detergents profoundly affect inhibitor potencies against both cyclo-oxygenase isoforms.
    Ouellet M; Falgueyret JP; Percival MD
    Biochem J; 2004 Feb; 377(Pt 3):675-84. PubMed ID: 14510637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An inhibitor of type-1 cyclo-oxygenase in tissues from human pregnancy.
    Willix-Payne DJ; Sun MY; Elder MG; Bennett PR; Sullivan MH
    Acta Obstet Gynecol Scand; 1999 May; 78(5):403-7. PubMed ID: 10326885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [COX-2 inhibitors: current status and outlook].
    Dannhardt G; Hahn L
    Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
    [No Abstract]   [Full Text] [Related]  

  • 33. Expression of cyclooxygenase isoforms in normal human skin and chronic venous ulcers.
    Abd-El-Aleem SA; Ferguson MW; Appleton I; Bhowmick A; McCollum CN; Ireland GW
    J Pathol; 2001 Dec; 195(5):616-23. PubMed ID: 11745699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Specific roles of cyclooxygenase-1 and cyclooxygenase-2 in lipopolysaccharide-induced fever and Fos expression in rat brain.
    Zhang YH; Lu J; Elmquist JK; Saper CB
    J Comp Neurol; 2003 Aug; 463(1):3-12. PubMed ID: 12811798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production.
    Johnson PM; Vogt SK; Burney MW; Muglia LJ
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E650-6. PubMed ID: 11832369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. COX-2 and COX-2 enzyme inhibition.
    Conti P
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):I-II. PubMed ID: 14552697
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
    Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
    Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
    Vanegas H
    Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
    [No Abstract]   [Full Text] [Related]  

  • 39. Cyclo-oxygenase isoenzymes. Structural basis for selective inhibition of cyclo-oxygenases by anti-inflammatory agents.
    Fiorucci S; Antonelli E
    Dig Liver Dis; 2001 Dec; 33 Suppl 2():S2-7. PubMed ID: 11827358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of cyclooxygenase-2 in brain during acute and chronic ethanol treatment and ethanol withdrawal.
    Knapp DJ; Crews FT
    Alcohol Clin Exp Res; 1999 Apr; 23(4):633-43. PubMed ID: 10235299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.